159 related articles for article (PubMed ID: 22162776)
21. Topical Diclofenac-Loaded Liposomes Ameliorate Laser-Induced Choroidal Neovascularization in Mice and Non-Human Primates.
Shimazawa M; Inoue Y; Masuda T; Onodera R; Tahara K; Shimizu Y; Mibe Y; Tsuruma K; Takeuchi H; Hara H
Curr Neurovasc Res; 2017; 14(1):46-52. PubMed ID: 27823554
[TBL] [Abstract][Full Text] [Related]
22. Antiangiogenic effects of tivozanib, an oral VEGF receptor tyrosine kinase inhibitor, on experimental choroidal neovascularization in mice.
Kang S; Roh YJ; Kim IB
Exp Eye Res; 2013 Jul; 112():125-33. PubMed ID: 23701975
[TBL] [Abstract][Full Text] [Related]
23. Visible-Light Optical Coherence Tomography Angiography for Monitoring Laser-Induced Choroidal Neovascularization in Mice.
Shah RS; Soetikno BT; Yi J; Liu W; Skondra D; Zhang HF; Fawzi AA
Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT86-95. PubMed ID: 27409510
[TBL] [Abstract][Full Text] [Related]
24. Blockage of PI3K/mTOR Pathways Inhibits Laser-Induced Choroidal Neovascularization and Improves Outcomes Relative to VEGF-A Suppression Alone.
Ma J; Sun Y; López FJ; Adamson P; Kurali E; Lashkari K
Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3138-44. PubMed ID: 27304845
[TBL] [Abstract][Full Text] [Related]
25. Soluble EphB4 regulates choroidal endothelial cell function and inhibits laser-induced choroidal neovascularization.
He S; Ding Y; Zhou J; Krasnoperov V; Zozulya S; Kumar SR; Ryan SJ; Gill PS; Hinton DR
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4772-9. PubMed ID: 16303978
[TBL] [Abstract][Full Text] [Related]
26. Lentivirus vector-mediated knockdown of erythropoietin-producing hepatocellular carcinoma receptors B4 inhibits laser-induced choroidal neovascularization.
Du J; Zhao W; Wang Y; Cai Y
J Ocul Pharmacol Ther; 2013 Feb; 29(1):14-22. PubMed ID: 23035975
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA.
Gu L; Chen H; Tuo J; Gao X; Chen L
Exp Eye Res; 2010 Sep; 91(3):433-9. PubMed ID: 20599960
[TBL] [Abstract][Full Text] [Related]
28. In vivo imaging of a new indocyanine green micelle formulation in an animal model of laser-induced choroidal neovascularization.
Meyer J; Cunea A; Sonntag-Bensch D; Welker P; Licha K; Holz FG; Schmitz-Valckenberg S
Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6204-12. PubMed ID: 25190666
[TBL] [Abstract][Full Text] [Related]
29. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
Kim KL; Suh W
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
[TBL] [Abstract][Full Text] [Related]
30. Effect of chromogranin A-derived vasostatin-1 on laser-induced choroidal neovascularization in the mouse.
Maestroni S; Maestroni A; Ceglia S; Tremolada G; Mancino M; Sacchi A; Lattanzio R; Zucchiatti I; Corti A; Bandello F; Zerbini G
Acta Ophthalmol; 2015 May; 93(3):e218-22. PubMed ID: 25271003
[TBL] [Abstract][Full Text] [Related]
31. Cytochrome P450 oxidase 2J inhibition suppresses choroidal neovascularization in mice.
Gong Y; Tomita Y; Edin ML; Ren A; Ko M; Yang J; Bull E; Zeldin DC; Hellström A; Fu Z; Smith LEH
Metabolism; 2022 Sep; 134():155266. PubMed ID: 35868524
[TBL] [Abstract][Full Text] [Related]
32. Annexin A2 promotes choroidal neovascularization by increasing vascular endothelial growth factor expression in a rat model of argon laser coagulation-induced choroidal neovascularization.
Zhao SH; Pan DY; Zhang Y; Wu JH; Liu X; Xu Y
Chin Med J (Engl); 2010 Mar; 123(6):713-21. PubMed ID: 20368092
[TBL] [Abstract][Full Text] [Related]
33. Antiangiogenic effects of axitinib, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, on laser-induced choroidal neovascularization in mice.
Kang S; Roh CR; Cho WK; Park KC; Yang KJ; Choi HS; Kim SH; Roh YJ
Curr Eye Res; 2013 Jan; 38(1):119-27. PubMed ID: 23013553
[TBL] [Abstract][Full Text] [Related]
34. Correlation of in vivo and in vitro methods in measuring choroidal vascularization volumes using a subretinal injection induced choroidal neovascularization model.
Nie C; Zhang MN; Zhao HW; Olsen TD; Jackman K; Hu LN; Ma WP; Chen XF; Wang J; Zhang Y; Gao TS; Uehara H; Ambati BK; Luo L
Chin Med J (Engl); 2015 Jun; 128(11):1516-22. PubMed ID: 26021510
[TBL] [Abstract][Full Text] [Related]
35. Bone marrow transplantation transfers age-related susceptibility to neovascular remodeling in murine laser-induced choroidal neovascularization.
Espinosa-Heidmann DG; Malek G; Mettu PS; Caicedo A; Saloupis P; Gach S; Dunnon AK; Hu P; Spiga MG; Cousins SW
Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7439-49. PubMed ID: 24135751
[TBL] [Abstract][Full Text] [Related]
36. TNF-α mediates choroidal neovascularization by upregulating VEGF expression in RPE through ROS-dependent β-catenin activation.
Wang H; Han X; Wittchen ES; Hartnett ME
Mol Vis; 2016; 22():116-28. PubMed ID: 26900328
[TBL] [Abstract][Full Text] [Related]
37. Suppression of laser-induced choroidal neovascularization by a CCR3 antagonist.
Mizutani T; Ashikari M; Tokoro M; Nozaki M; Ogura Y
Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1564-72. PubMed ID: 23404125
[TBL] [Abstract][Full Text] [Related]
38. Histamine H4 receptor as a new therapeutic target for choroidal neovascularization in age-related macular degeneration.
Kaneko H; Ye F; Ijima R; Kachi S; Kato S; Nagaya M; Higuchi A; Terasaki H
Br J Pharmacol; 2014 Aug; 171(15):3754-63. PubMed ID: 24787705
[TBL] [Abstract][Full Text] [Related]
39. Activated protein C induces suppression and regression of choroidal neovascularization- A murine model.
Livnat T; Weinberger Y; Budnik I; Deitch I; Dahbash M; Sella R; Dardik R; Kenet G; Nisgav Y; Weinberger D
Exp Eye Res; 2019 Sep; 186():107695. PubMed ID: 31201804
[TBL] [Abstract][Full Text] [Related]
40. The Urokinase Receptor-Derived Peptide UPARANT Mitigates Angiogenesis in a Mouse Model of Laser-Induced Choroidal Neovascularization.
Cammalleri M; Dal Monte M; Locri F; Lista L; Aronsson M; Kvanta A; Rusciano D; De Rosa M; Pavone V; André H; Bagnoli P
Invest Ophthalmol Vis Sci; 2016 May; 57(6):2600–2611. PubMed ID: 27168367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
